The Medibank Private Ltd (ASX: MPL) share price is heading south on Thursday following a broader market slump.
This comes amid the private health insurer announcing some key dates for its 2022 calendar this morning.
At the time of writing, Medibank shares are fetching at $3.165, down 0.47%. In comparison, the S&P/ASX 200 Index (ASX: XJO) is struggling throughout the day to trade at 6,977.9 points, down 1.23%.
What’s Medibank’s agenda for the remainder of 2022?
With the year almost halfway done, Australia’s premier health insurance provider, Medibank released its key dates for 2022.
The most important date in the near term is on 18 August, when the company will deliver its full year results.
In addition to its 12-month performance report, a 2022 final dividend will also be announced by the board.
The ex-dividend date is scheduled to occur the following month on 7 September. This is when investors must have purchased Medibank shares to be eligible for payment of the upcoming dividend.
The date for when shareholders will receive the final dividend payment is set for 29 September.
For context, Medibank returned to shareholders a fully-franked final dividend payment of 6.9 cents per share for FY21.
Lastly, the company will hold its 2022 annual general meeting (AGM) on 16 November. This will likely recap the events over the last 12 months, as well as the near-term outlook for the private health insurer.
Medibank share price snapshot
Since this time last year, the Medibank share price has travelled in circles to post a gain of around 5%.
When looking at year to date, its shares have traversed the other way, down 5%.
Based on today’s price, Medibank commands a market capitalisation of roughly $8.73 billion.
The company currently has a trailing dividend yield of 4.10% and a price-to-earnings (P/E) ratio of 20.06.
The post Own Medibank shares? Here’s what to watch over the coming months appeared first on The Motley Fool Australia.
Should you invest $1,000 in Medibank right now?
Before you consider Medibank, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
- How big will the Medibank dividend be in 2022?
- The Medibank share price has leapt 5% in a month. Could it be on the comeback trail in May?
- This ASX 200 healthcare share has a fully franked dividend yield over 4% right now
- Why is the Medibank share price trailing NIB over the past year?
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/TRxiAg3